A citation-based method for searching scientific literature

Dennis S Chi, Fernanda Musa, Fanny Dao, Oliver Zivanovic, Yukio Sonoda, Mario M Leitao, Douglas A Levine, Ginger J Gardner, Nadeem R Abu-Rustum, Richard R Barakat. Gynecol Oncol 2012
Times Cited: 183







List of co-cited articles
672 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
79

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
630
62

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
40


Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Dennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, Yukio Sonoda, Nadeem R Abu-Rustum, Douglas A Levine, Matthew W Guile, Robert E Bristow, Carol Aghajanian, Richard R Barakat. Gynecol Oncol 2009
375
32

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti, Gabriella Ferrandina, Giuseppe Vizzielli, Francesco Fanfani, Valerio Gallotta, Vito Chiantera, Barbara Costantini, Pasquale Alessandro Margariti, Salvatore Gueli Alletti, Francesco Cosentino,[...]. Eur J Cancer 2016
200
23

Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Karl C Podratz, William A Cliby. Am J Obstet Gynecol 2007
193
21

The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.
Barry Rosen, Stephane Laframboise, Sarah Ferguson, Jason Dodge, Marcus Bernardini, Joan Murphy, Yakir Segev, Ping Sun, Steven A Narod. Gynecol Oncol 2014
75
26


What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, J Huh, L Haddad, N R Abu-Rustum, Y Sonoda, D A Levine, M Hensley, R R Barakat. Gynecol Oncol 2006
418
19

Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center.
Jennifer J Mueller, Qin C Zhou, Alexia Iasonos, Roisin E O'Cearbhaill, Farah A Alvi, Amr El Haraki, Ane Gerda Zahl Eriksson, Ginger J Gardner, Yukio Sonoda, Douglas A Levine,[...]. Gynecol Oncol 2016
73
26

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
William E Winter, G Larry Maxwell, Chunqiao Tian, Jay W Carlson, Robert F Ozols, Peter G Rose, Maurie Markman, Deborah K Armstrong, Franco Muggia, William P McGuire. J Clin Oncol 2007
585
18

Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, C Robert Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. Obstet Gynecol 2006
311
17

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Deborah K Armstrong, Brian Bundy, Lari Wenzel, Helen Q Huang, Rebecca Baergen, Shashikant Lele, Larry J Copeland, Joan L Walker, Robert A Burger. N Engl J Med 2006
17

Use and Effectiveness of Neoadjuvant Chemotherapy for Treatment of Ovarian Cancer.
Larissa A Meyer, Angel M Cronin, Charlotte C Sun, Kristin Bixel, Michael A Bookman, Mihaela C Cristea, Jennifer J Griggs, Charles F Levenback, Robert A Burger, Gina Mantia-Smaldone,[...]. J Clin Oncol 2016
85
20


Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602.
Takashi Onda, Toyomi Satoh, Toshiaki Saito, Takahiro Kasamatsu, Toru Nakanishi, Kenichi Nakamura, Masashi Wakabayashi, Kazuhiro Takehara, Motoaki Saito, Kimio Ushijima,[...]. Eur J Cancer 2016
117
16

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
206
16

Overall Survival Following Neoadjuvant Chemotherapy vs Primary Cytoreductive Surgery in Women With Epithelial Ovarian Cancer: Analysis of the National Cancer Database.
J Alejandro Rauh-Hain, Alexander Melamed, Alexi Wright, Allison Gockley, Joel T Clemmer, John O Schorge, Marcela G Del Carmen, Nancy L Keating. JAMA Oncol 2017
61
26

The role of neoadjuvant chemotherapy in the management of patients with advanced stage ovarian cancer: survey results from members of the Society of Gynecologic Oncologists.
Summer B Dewdney, B J Rimel, Andrew J Reinhart, Nora T Kizer, Rebecca A Brooks, L Stewart Massad, Israel Zighelboim. Gynecol Oncol 2010
65
23

Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Mathieu Luyckx, Eric Leblanc, Thomas Filleron, Philippe Morice, Emile Darai, Jean-Marc Classe, Gwenaël Ferron, Eberhard Stoeckle, Christophe Pomel, Bénédicte Vinet,[...]. Int J Gynecol Cancer 2012
76
18

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
William E Winter, G Larry Maxwell, Chunqiao Tian, Michael J Sundborg, G Scott Rose, Peter G Rose, Stephen C Rubin, Franco Muggia, William P McGuire. J Clin Oncol 2008
235
14

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Giovanni D Aletti, Eric L Eisenhauer, Antonio Santillan, Allison Axtell, Giacomo Aletti, Christine Holschneider, Dennis S Chi, Robert E Bristow, William A Cliby. Gynecol Oncol 2011
151
14

A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Alfredo Ercoli, Domenica Lorusso, Marco Rossi, Giovanni Scambia. Ann Surg Oncol 2006
183
14

Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma.
J Alejandro Rauh-Hain, Caroline C Nitschmann, Micheal J Worley, Leslie S Bradford, Ross S Berkowitz, John O Schorge, Susana M Campos, Marcela G del Carmen, Neil S Horowitz. Gynecol Oncol 2013
72
18

Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer.
J Alejandro Rauh-Hain, Noah Rodriguez, Whitfield B Growdon, A K Goodman, David M Boruta, Neil S Horowitz, Marcela G del Carmen, John O Schorge. Ann Surg Oncol 2012
58
22

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.
Willemien J van Driel, Simone N Koole, Karolina Sikorska, Jules H Schagen van Leeuwen, Henk W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Jacobus van der Velden, Henriëtte J Arts, Leon F A G Massuger,[...]. N Engl J Med 2018
566
13

Secondary surgical cytoreduction for advanced ovarian carcinoma.
Peter G Rose, Stacy Nerenstone, Mark F Brady, Daniel Clarke-Pearson, George Olt, Stephen C Rubin, David H Moore, James M Small. N Engl J Med 2004
248
12

Is the easier way ever the better way?
Dennis S Chi, Robert E Bristow, Deborah K Armstrong, Beth Y Karlan. J Clin Oncol 2011
60
20

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial.
Hannah S van Meurs, Parvin Tajik, Michel H P Hof, Ignace Vergote, Gemma G Kenter, Ben Willem J Mol, Marrije R Buist, Patrick M Bossuyt. Eur J Cancer 2013
72
16

Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian cancer and leads to improved survival in stage IV disease.
June Y Hou, Michael G Kelly, Herbert Yu, Jessica N McAlpine, Masoud Azodi, Thomas J Rutherford, Peter E Schwartz. Gynecol Oncol 2007
123
12

Introduction of staging laparoscopy in the management of advanced epithelial ovarian, tubal and peritoneal cancer: impact on prognosis in a single institution experience.
A Fagotti, G Vizzielli, F Fanfani, B Costantini, G Ferrandina, V Gallotta, S Gueli Alletti, L Tortorella, G Scambia. Gynecol Oncol 2013
72
15

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.
Scott M Eisenkop, Nick M Spirtos, Richard L Friedman, Wei-Chien Michael Lin, Albert L Pisani, Sergio Perticucci. Gynecol Oncol 2003
267
11

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S Horowitz, Austin Miller, Bunja Rungruang, Scott D Richard, Noah Rodriguez, Michael A Bookman, Chad A Hamilton, Thomas C Krivak, G Larry Maxwell. J Clin Oncol 2015
142
11

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
11

Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
I Vergote, I De Wever, W Tjalma, M Van Gramberen, J Decloedt, P van Dam. Gynecol Oncol 1998
265
11

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov, Revathy B Iyer, Qin Zhou, Alexia Iasonos, Harold Paul, Masayoshi Hosaka,[...]. Gynecol Oncol 2014
124
10

Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Giorgia Garganese, Giuseppe Vizzielli, Vito Carone, Maria Giovanna Salerno, Giovanni Scambia. Am J Obstet Gynecol 2008
160
10

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
W J Hoskins, W P McGuire, M F Brady, H D Homesley, W T Creasman, M Berman, H Ball, J S Berek. Am J Obstet Gynecol 1994
530
10

Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Ahmed Elattar, Andrew Bryant, Brett A Winter-Roach, Mohamed Hatem, Raj Naik. Cochrane Database Syst Rev 2011
216
10

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.
Philipp Harter, Zelal M Muallem, Christine Buhrmann, Dietmar Lorenz, Christine Kaub, Rita Hils, Stefan Kommoss, Florian Heitz, Alexander Traut, Andreas du Bois. Gynecol Oncol 2011
130
10


2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
Gavin C E Stuart, Henry Kitchener, Monica Bacon, Andreas duBois, Michael Friedlander, Jonathan Ledermann, Christian Marth, Tate Thigpen, Edward Trimble. Int J Gynecol Cancer 2011
285
10


Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer.
W P McGuire, W J Hoskins, M F Brady, P R Kucera, E E Partridge, K Y Look, D L Clarke-Pearson, M Davidson. N Engl J Med 1996
10



Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials.
Ignace Vergote, Corneel Coens, Matthew Nankivell, Gunnar B Kristensen, Mahesh K B Parmar, Tom Ehlen, Gordon C Jayson, Nick Johnson, Ann Marie Swart, René Verheijen,[...]. Lancet Oncol 2018
106
10

Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
Takashi Onda, Toyomi Satoh, Gakuto Ogawa, Toshiaki Saito, Takahiro Kasamatsu, Toru Nakanishi, Tomonori Mizutani, Kazuhiro Takehara, Aikou Okamoto, Kimio Ushijima,[...]. Eur J Cancer 2020
53
18



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.